新光药业(300519.SZ)：暂不涉及生物药（抗体类、重组蛋白类或融合蛋白类）的研发与生产

Core Viewpoint - The company primarily engages in the research, production, and sales of traditional Chinese medicine, chemical drugs, and health food, and currently does not involve in the research and production of biopharmaceuticals such as antibodies, recombinant proteins, or fusion proteins [1] Company Overview - The company is identified as 新光药业 (Xinguang Pharmaceutical) with the stock code 300519.SZ [1] - The company's main business activities include the development and sales of traditional Chinese medicine, chemical drugs, and health food products [1] Industry Position - The company has not yet ventured into the biopharmaceutical sector, which includes the development of antibody-based therapies and recombinant proteins [1]